跳至主要内容
临床试验/CTRI/2020/11/029352
CTRI/2020/11/029352进行中(未招募)4 期

Evaluation of Progression of Prediabetes with Low Carbohydrate High Fat (LCHF) diet and Pharmacotherapy (Metformin and Sitagliptin).

Siddhartha Medical college and Government General hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Pre-diabetic patients (FPG ï?  110-125mg/dL, IGT ï?  140-200mg/dL, HbA1c -5.7 to 6.4%)
  • - Age > 25 yr
  • - Over weight or obese patients with BMI > 25kg/m2
  • - Those with strong family history(first degree relative with diabetes) and associated factors of diabetes
  • - Pre-diabetics patients with hypertension (B.P. >140/90 mm Hg).
  • - PCOS (Polycystic ovary syndrome)
  • - Subjects with Life Style modifications (balanced diet, include a physical activity at least 150min/week, maintain regular & adequate sleep, no smoking and alcohol) are included.

排除标准

  • - Age > 60years
  • - Diabetic patients (HbA1c > 6.5%, FPG >125mg/dL).
  • - Type - I diabetes patients.
  • - Gestational diabetic patients.
  • - Known endocrine diseases (Hypo/hyperthyroidism, Cushingâ??s syndrome).
  • - Patients on diabetogenic drugs (Corticosteroids, Antibiotics (Fluoroquinolones), β-blockers, Thiazide and Thiazide-Like Diuretics, 2nd Generation Antipsychotics, Calcineurin Inhibitors (CNIs),Protease Inhibitors etc.,
  • - Patients taking drugs which produce hypertension (Glucocorticoids, testosterone, ethyl estradiol, adrenergic agents, ergot alkaloids, MAO inhibitors, NSAID, Cyclosporine, Bromocriptine, alcohol, etc.,)
  • - Patients with HIV, Tuberculosis and other chronic infectious diseases.
  • - Patients on anti-obesity drugs.
  • - Patients with known cardiac renal, hepatic conditions, respiratory failure and psychological disorders.

研究者

发起方
Siddhartha Medical college and Government General hospital

相似试验